Industry

Patient engagement leader expands commitment to driving digital health technology as pandemic continues BETHESDA, Md,–(BUSINESS WIRE)–#Adventist–Patients using a remote patient monitoring program developed by Get Well, a global leader in digital patient engagement, to monitor and report COVID-19 symptoms had lowered hospitalization rates, spent less time in the intensive care unit, and had shorter overall … [Read more…]

OB-GYN Practice in Florida Uses PatientPop Technology to Enhance Its Online Presence SANTA MONICA, Calif.–(BUSINESS WIRE)–PatientPop, a market leader in practice growth technology, today announced that its successful partnership with OB-GYN Dr. Alan B. Patterson has resulted in a significant increase in new patients and business outcomes. Dr. Patterson began leveraging PatientPop’s services in 2017 … [Read more…]

Achieved record net product revenue of $25.3M – a 15% increase from Q1 ’22, and a 34% increase from same period prior year on a pro forma basis Ended Q2 with $111.6M in cash, cash equivalents and short-term investments Reaffirms full-year total net product revenue of $105M-$120M; $50M in synergies by year-end, 2022 year-end cash … [Read more…]

-The company-sponsored Phase 1/2 study is evaluating a cryopreserved, readily available formulation of GDA-201 for the treatment of follicular and diffuse large B cell lymphomas – BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapy candidates for patients with hematologic and solid cancers and other serious diseases, announces dosing … [Read more…]

ADI-001 demonstrated 75% CR and ORR rate across all dose levels with favorable safety and tolerability profile in patients with relapsed/refractory high grade aggressive NHL, as of May 31, 2022 data-cut date ADI-001 received FDA Fast Track Designation Strong balance sheet with $304.3 million in cash and cash equivalents, as adjusted for anticipated proceeds from … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Oncology Drugs Market (2022-2027) by Drug Class, Indication, End-user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Oncology Drugs Market is estimated to be USD 156.49 Bn in 2022 and is expected to reach USD 224.35 Bn by 2027, growing … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic drug delivery system market will reach $ 30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Pain Market (2022-2027) by Type, Disease Indication, Application, and Geography, Competitive Analysis, Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The Global Cancer Pain Market is estimated to be USD 8.14 Bn in 2022 and is projected to reach USD 10.45 Bn by 2027, growing at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Pain Management Devices Market 2021-2031 by Product, Application, Mode of Purchase, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The global pain management devices market will reach $9,971.6 million by 2031, growing by 8.3% annually over 2021-2031, driven by the growing demand for chronic pain management … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Mini Bioreactors and Micro Bioreactors Market, Distribution by Type of Cell Culture, Mode of Operation, End User and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering. The ‘Mini Bioreactors and Micro Bioreactors Market, 2022-2035’ report features an extensive study of the current landscape and the … [Read more…]